BRVE Insider Erez Chimovits Buys $30M in Cluster Deal
A new Form 4 filing shows Erez Chimovits, a Director and 10%+ Owner of Braveheart Bio, Inc. (BRVE), purchased 1,666,667 shares on the open market on 2026-08-07 at $18.00 per share, a total outlay of $30,000,006.00. Following the purchase, Chimovits holds 11,901,826 shares indirectly, through a trust or entity structure rather than in a personal … Read more